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This study aimed to test multidrug resistant isolates from hospitalised green turtles (Chelonia mydas) and their environment in
North Queensland, Australia, for in vitro susceptibility to bacteriophages. Seventy-one Gram-negative bacteria were isolated from
green turtle eye swabs and water samples. Broth microdilution tests were used to determine antibiotic susceptibility. All isolates
were resistant to at least two antibiotics, with 24% being resistant to seven of the eight antibiotics. Highest resistance rates were
detected to enrofloxacin (77%) and ampicillin (69.2%). More than 50% resistance was also found to amoxicillin/clavulanic acid
(62.5%), ceftiofur (53.8%), and erythromycin (53.3%). All the enriched phage filtrate mixtures resulted in the lysis of one or more of
the multidrug resistant bacteria, including Vibrio harveyi and V. parahaemolyticus. These results indicate that antibiotic resistance
is common in Gram-negative bacteria isolated from hospitalised sea turtles and their marine environment in North Queensland,
supporting global concern over the rapid evolution of multidrug resistant genes in the environment. Using virulent bacteriophages
as antibiotic alternatives would not only be beneficial to turtle health but also prevent further addition of multidrug resistant genes
to coastal waters.
1. Introduction
The increasing quantities of antibiotics released in the envi-
ronment due to anthropogenic activities are selecting for
resistant bacterial strains in all environments. Large-scale
applications of antibiotics, other than for human therapy,
include use in aquaculture and agriculture, use as animal
growth promoters, and use for culture sterility in research and
industry, as well as other therapeutic and prophylactic use in
animal hospitals and rehabilitation centres [1, 2].
Due to the severe debilitation of sea turtles on entry to
rehabilitation centres, they are often treated with a broad-
spectrum antibiotic both prophylactically and therapeutically
against microbial diseases without prior antibiotic suscep-
tibility testing [3]. Broad-spectrum antibiotics can further
jeopardise the health of a green turtle (Chelonia mydas) by
killing the intestinal bacterial flora they rely on for hind-gut
fermentation. A damaged intestinal bacterial flora increases
the risk of intestinal disease and malnutrition, enhancing the
green turtle’s susceptibility to bacterial infection and thus
eliciting a treatment cascade. Furthermore, the discharge of
those antibiotics into aquatic environments via waste waters
may destroy or inhibit important environmental bacteria
[4, 5].
Recently, bacteriophages or phages have gained increased
attention as an alternative to antibiotics and other antibac-
terial chemicals in order to reduce the spread of multidrug
resistant bacteria and control bacterial diseases where antibi-
otics are no longer effective [6]. Sea turtles’ eyes are in direct
contact with the surrounding environment and exposed to
physical damage and bacterial infections even during captive
care [7, 8]. In this study, we isolated and performed antibiotic
sensitivity tests on bacterial isolates from hospitalised green
turtle eyes. Multidrug resistant isolates were subsequently
tested for in vitro susceptibility to bacteriophages in order to
assess their potential use in rehabilitation settings.
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Table 1: Epidemiological cut-offs (mg/l) for the eight antibiotics tested and the initial working concentrations (mg/l) of the eight antibiotics
used in the MIC tests.
Antibiotic agents1
Am/c Amp. Cef. Chl. Dox. Enr. Ery. Tm/s
Epidemiological cut-offs (mg/l) >8/4 >4 >2 >16 >8 >0.25 >2 >0.5/9.5
Initial conc. (mg/l) 128/64 64 16.2 64 35.5 16 33.2 32/608
1Am/c: amoxicillin/clavulanic acid; Amp.: ampicillin; Cef.: ceftiofur; Chl.: chloramphenicol; Dox.: doxycycline; Enr.: enrofloxacin; Ery.: erythromycin; Tm/s:
trimethoprim/sulfadiazine.
2. Materials and Methods
2.1. Sampling. A total of seven captive green sea turtles, two
of them from the ReefHQ Turtle Hospital in Townsville and
five from the Fitzroy Island Rehabilitation Centre in Cairns,
were sampled between June and July 2014 in accordance with
the following permits: WISP14626814 from the Department
of Environmental and Heritage Protection, A2026 Animal
Ethics, and G14/36896.1 from the Great Barrier Reef Marine
Park Authority. A total of 14 swabs were taken from under the
dorsal eyelid of both eyes on each turtle. Water samples were
collected from the turtle holding tanks at ReefHQand Fitzroy
Island Rehabilitation Centre. A water sample was collected
from the display tank at ReefHQ as hospitalised turtles are
often held there. Two one-litre surface water samples were
also collected from the coastal environment offMagnetic and
Orpheus Islands, North Queensland.
2.2. Isolation of Bacteria. The swabs were plated onto five
agars, from less selective to most selective, 5% sheep blood
(Acumedia, CellBioSciences), marine salts enriched tryp-
tose (Oxoid), McConkey agar with marine salts (Oxoid),
thiosulfate-citrate-bile salts-sucrose agar (TCBS) (Acumedia,
CellBioSciences), and marine salts agar with phenylethyl
alcohol (Oxoid), and incubated at 30∘C overnight. Water
samples were filtered through 0.45 𝜇m mesh and 90mm
diameter glass microfibre filters (Whatman) with a dry
vacuum pump/compressor (Model 2511 Welch), and the
filters were cultured for bacteria using the same media and
incubation conditions as the eye swabs. Isolated bacterial
colonies were selected based on their different morphologies
and purified by individually plating each selected colony onto
blood agar withmarine salts and incubated at 30∘Covernight.
Purified colonies were grouped using Gram staining, oxi-
dase, catalase, and spot indole tests. Each bacterial isolate
was subjected to antibiotic susceptibility tests using broth
microdilution plates to detect their susceptibility to antibi-
otics. Bacterial isolates that showed multidrug resistance (to
at least 3 antibiotics) were therefore selected for more specific
identification using the following tests: growth on TCBS
agar for sucrose fermentation, growth onMcConkey agar for
lactose fermentation, and motility using the “hanging drop”
microscopic technique. Final identification to species level
wasfinal carried out using Micro Sys plates for Vibrio spp.
or Biolog (CellBioSciences Pty Ltd, Heidelberg, VIC) tests.
2.3. Broth Microdilution Plate Preparation. Broth microdilu-
tion plates were prepared by inoculating 100 𝜇l of artificial
sea water (ASW) in each well of a 96-well flat-bottom
plate (Corning). Each well in the first column (A–H) was
then inoculated with 100 𝜇l of 8 different analytically pure
antibiotics (Sigma-Aldrich) resulting in initial concentra-
tions shown in Table 1. Twelve 2-fold dilutions of the initial
antibiotic concentrations were carried across each row. Broth
microdilution plates were stored in a −20∘C freezer until
required.
2.4. Determination of Minimum Inhibitory Concentrations
and Epidemiological Cut-Offs. Bacterial isolates were inocu-
lated into sterile Mueller-Hinton broth containing 1.5% salts
(from ASW). This culture was incubated in an orbital shaker
for 8–10 hours at a temperature of 30∘C and a rotation
speed of 150 revmin−1. Bacterial density was brought to 0.5
McFarland standard by using a spectrophotometer set at
600 nm wavelength. A 100𝜇l aliquot from the 0.5 McFarland
bacterial suspension was then inoculated in each well with
an 8-tip multichannel pipette starting from the highest dilu-
tion. Inoculated broth microdilution plates were incubated
at 30∘C overnight. A control plate was inoculated with
an ATCC 25922 Escherichia coli strain in order to assess
whether antibiotics performed as expected and check that the
marine salts media would not negatively impact on antibiotic
performance. Minimum inhibitory concentrations (MICs)
were determined using the Clinical and Laboratory Stan-
dards Institute (CLSI) method [9]. Epidemiological cut-
offs (ECOFFs) were determined as the upper limits of the
MICs distribution curves (upper limit of the wild-type bac-
terial strain). Repeats were subsequently performed with the
bacterial isolates that showed resistance to at least three
antibiotics.
2.5. Bacteriophage Enrichment. Selected bacterial isolates
were subcultured in nutrient broth and incubated at 30∘C for
5–8 hours in an orbital shaker at a rotation speed of
150 revmin−1. Water from the waste water of an extensive
prawn farm in Thailand and from a turtle holding tank at
ReefHQ was used as water sources for bacteriophage ampli-
fication. A 2ml aliquot of the bacterial broths was combined
with 50ml of nutrient broth (with doubled nutrient and
salts concentrations) and 50ml of water. The protocol was
repeated for all the bacterial samples and both the water
sources (Thailand and ReefHQ). Cultures were then incu-
bated in an orbital shaker overnight at 30∘Cat a rotation speed
of 60 revmin−1. After incubation, 45ml of the cultures was
centrifuged at 5000𝑔 (Beckman Coulter Allegra X22R) for
20min and the supernatant filtered through 0.45 𝜇m sterile
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syringe filters (Sarstedt) to remove any bacteria and collect
bacteriophage.
2.6. Bacteriophage Sensitivity Test. An 800 𝜇l aliquot of each
bacterial isolate was inoculated on marine agar with a
micropipette and spread over the entire plate in order to form
a bacterial lawn and allowed to dry for about 30min. A 20 𝜇l
aliquot from each of the bacteriophage-enriched filtrates was
spot-inoculated on each bacterial lawn. Plaques radiating
from the phage-enriched filtrate were considered as a positive
phage infection of the bacterial lawn. Control plates without
bacterial lawns were prepared and inoculated with phage-
enriched filtrate drops from both sources (as above) in order
to check for contamination of the water samples.
3. Results
3.1. Bacterial Identification. Seventy-one bacterial isolates
were tested for antibiotic resistance (30 from ReefHQ Turtle
Hospital, 20 from Fitzroy Island Turtle Rehabilitation Centre,
13 from Magnetic Island coastal water, and eight from
Orpheus Island coastal water). Eleven of the bacterial strains
that showed multidrug resistance to a minimum of three
antibiotics were identified to at least the genus level. The pre-
dominant isolates wereVibrio spp. (73% of selected bacteria).
Three (27%) of the selected bacteria were Pseudomonas spp.
(Table 2). Vibrio harveyi and V. parahaemolyticus were two
potential pathogens identified to species level (Table 2).
3.2. Antibiotic Susceptibility. All isolates were resistant to at
least two antibiotics, with 24% being resistant to seven of
the eight antibiotics tested (Figure 1). The antibiotics that
encountered the highest prevalence of resistance were ampi-
cillin (range 40 to 69.2%), enrofloxacin (range 16.6–77%),
amoxicillin plus clavulanic acid (range 15 to 62.5%), and
ceftiofur (range 10–53.8%). An unexpected high prevalence
of resistant bacteria was found in the coastal waters compared
with the turtle’s eye: 77% in water from Magnetic Island
and 62.5% in that from Orpheus to enrofloxacin and 53.8%
and 62.5% resistance in each coastal water, respectively, to
amoxicillin and clavulanic acid (Table 2). Resistance preva-
lence to erythromycin was greater in the eye bacteria: 53.3%
from ReefHQ and 50% from Fitzroy, as against 38.5% in
coastal water fromMagnetic Island and 12.5% fromOrpheus.
Resistance prevalence to doxycycline and thus all tetracycline
antibiotics was moderate in isolates from ReefHQ (30%) and
Magnetic Island (23%) and low for isolates from Fitzroy (5%)
and Orpheus (0%). Low rates of antibiotic resistance were
detected to chloramphenicol (range 0–10%) and trimetho-
prim/sulfadiazine (0–16.5%). In fact, there was no resistance
to chloramphenicol observed in isolates from Orpheus and
Magnetic Islands shore water and no resistance to trimetho-
prim/sulfadiazine observed in isolates from Magnetic Island
shore water.
3.3. Bacteriophage Spot Tests. Seventy-two percent (72%) of
phages lysed at least their targeted bacteria. All the bacteria,
including V. harveyi and V. parahaemolyticus, were lysed by
at least one of the phage filtrates (Table 3).The ReefHQ phage
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Figure 1: Frequency of resistant bacterial isolates to the eight
antibiotics tested.
filtrate lysed only one of the bacteria, which was also lysed by
3Thailand filtrates. Two of the filtrates fromThailand (#1 and
#6) appeared to have lysed up to 4 bacterial isolates (Table 3).
4. Discussion
In this study, samples were taken from green turtle eyes in
order to test for the presence of antibiotic resistant bacteria
and their susceptibility to phage, an alternative treatment
method.Throughout the existing literature, bacterial samples
from sea turtles have been predominantly Gram-negative
strains taken from the nasopharyngeal and cloacal area [10–
12]. Gram-negative aerobic bacteria were also isolated from
the tanks of two sea turtle rehabilitation centres in the
North Queensland region and from the near-shore waters of
islands in the region. The ReefHQ sea turtle hospital in
Townsville treats debilitated sea turtles with five antibi-
otics, namely, amoxicillin trihydrate, enrofloxacin, trimetho-
prim/sulfadiazine, chloramphenicol, and oxytetracycline.
The Fitzroy Island sea turtle rehabilitation centre in Cairns
utilises enrofloxacin and oxytetracycline for the hospitalised
sea turtles.
It is expected that environments where antibiotic use is
high will select for a high level of antibiotic resistance in
isolated bacteria [13, 14]. Therefore, the higher number of
multidrug resistant bacteria from the rehabilitation centres
was not surprising. However, the resistance to some individ-
ual antibiotics was higher in coastal water bacterial isolates.
One would expect isolates from ReefHQ and Fitzroy Island
Rehabilitation Centres to have the greatest prevalence of
resistance to the broad-spectrum antibiotics enrofloxacin (a
fluoroquinolone) and oxytetracycline (a tetracycline antibi-
otic). The moderate prevalence of resistance to enrofloxacin
at both ReefHQ and Fitzroy Island Rehabilitation Cen-
tres was therefore expected, as was the lack of resistance
to doxycycline in the coastal waters. Furthermore, the
higher prevalence of the beta-lactam drugs and potentiated
sulphonamides (trimethoprim/sulfadiazine) in the ReefHQ
isolates compared to those from Fitzroy Island is also expect-
ed. What was unexpected was the high prevalence in coastal
waters of bacteria resistant to the fluoroquinolones and
broad-spectrum beta-lactam drugs.
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Table 2: Number of isolates from the four sampling sites1 at a minimum inhibitory concentration (MIC2) in mg/l against eight antibiotics.
(a)
Number of isolates (𝑛 = 30) at a MIC (mg/l) (ReefHQ)
Antibiotic agent ≤0.002 0.004 0.008 0.015 0.031 0.062 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 >256 % res
Amoxi./clav. 6 1 3 2 3 2 3 | 5 2 3 33.3
Ampicillin 8 3 2 2 | 2 2 3 8 50
Ceftiofur 8 1 1 2 1 1 3 2 6 | 5 16.6
Chloramphenicol 6 1 1 8 5 4 2 | 1 2 10
Doxycycline 2 3 2 1 1 7 | 7 2 30
Enrofloxacin 7 1 3 5 2 5 2 | 3 1 1 16.6
Erythromycin 6 1 1 2 1 3 | 10 6 53.3
Trim./sulf. 8 1 1 2 4 4 5 | 1 2 1 1 16.6
(b)
Number of isolates (𝑛 = 20) at a MIC (mg/l) (Fitzroy)
Antibiotic agent ≤0.002 0.004 0.008 0.015 0.031 0.062 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 >256 % res
Amoxi./clav. 1 6 3 2 4 1 | 1 1 1 15
Ampicillin 1 1 2 3 4 1 | 2 1 1 4 40
Ceftiofur 2 1 3 1 1 2 2 3 2 1 | 1 1 10
Chloramphenicol 1 2 2 9 3 1 | 2 10
Doxycycline 1 1 2 8 4 3 | 1 5
Enrofloxacin 1 2 3 4 6 | 3 1 20
Erythromycin 1 1 4 4 | 10 50
Trim./sulf. 1 4 1 6 5 2 | 1 5
(c)
Number of isolates (𝑛 = 13) at a MIC (mg/l) (Magnetic Island)
Antibiotic agent ≤0.002 0.004 0.008 0.015 0.031 0.062 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 >256 % res
Amoxi./clav. 1 1 1 1 1 1 | 1 2 1 3 53.8
Ampicillin 1 1 2 | 1 1 2 5 69.2
Ceftiofur 1 3 1 1 | 1 3 3 53.8
Chloramphenicol 1 2 1 1 5 3 | 0
Doxycycline 1 2 1 1 5 | 3 23
Enrofloxacin 2 1 | 2 3 2 3 77
Erythromycin 1 2 1 4 | 5 38.5
Trim./sulf. 4 5 3 1 | 0
(d)
Number of isolates (𝑛 = 8) at a MIC (mg/l) (Orpheus)
Antibiotic agent ≤0.002 0.004 0.008 0.015 0.031 0.062 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 >256 % res
Amoxi./clav. 3 | 1 1 2 1 62.5
Ampicillin 3 | 1 4 62.5
Ceftiofur 3 1 | 3 1 50
Chloramphenicol 2 1 4 1 | 0
Doxycycline 2 1 1 3 1 | 0
Enrofloxacin 2 1 | 2 1 2 62.5
Erythromycin 3 1 1 | 1 12.5
Trim./sulf. 3 3 1 | 1 12.5
1ReefHQ Turtle Hospital, Fitzroy Island Rehabilitation Centre, Magnetic Island, and Orpheus Island. 2Vertical bars (|) are the epidemiological cut-offs
(numbers in bold after | are counted as antibiotic resistant isolates). Last column is the percentage of resistant bacteria (% res) for each antibiotic.
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Table 3: Bacterial susceptibility to 11 bacteriophage filtrates.
Bacterial strain Source1 Bacteriophage filtrates
2
#1 #2 #3 #4 #5 #6 #7 #8 #9 #10 #11
(1) V. harveyi TE L1 L1
(2) Pseudomonas sp. TE L1
(3) V. orientalis TE L1
(4) Pseudomonas sp. TT L1 L1 L2
(5) V. harveyi DT L1 L1 L1 L1
(6) V. cyclitrophicus DT L1 L1
(7) V. harveyi MI L1 L1 L1
(8) V. parahaemolyticus MI L1 L1 L1
(9) Pseudomonas sp. TE L1 L1
(10) V. nereis TE L1 L1
(11) Vibrio sp. FI L1 L1
1TE: ReefHQ green turtle eye, TT: ReefHQ green turtle tank, DT: ReefHQ display tank, MI: Magnetic Island water, and FI: Fitzroy Island turtle tank. 2Phage
filtrates numbers (#1–11) correspond to their isolating strains ((1)–(11)) (L1: lysed by phage filtrate sourced from Thailand aquaculture waste waters and L2:
lysed by phage filtrate sourced from ReefHQ green turtle tank water).
Environmental bacterial resistance to quinolones (nali-
dixic acid), the parent drug of the fluoroquinolones such as
enrofloxacin, has been found to be more common in reports
from the Mediterranean Sea [15, 16] than in the Southern
Eastern United States [17] or Australia [18]. Thus, we would
expect to find a low prevalence of resistance to the fluoro-
quinolones, especially in coastal waters.This was not the case,
since, as Table 2 shows, both sea water samples had higher
numbers of resistant bacteria (e.g., 77% of bacteria isolated
from coastal water off Magnetic Island) than the rehabili-
tation centres, and the results show a higher prevalence of
resistance than previous antibiotic surveillance reports from
Australia [19]. Although testing for resistance genes was not
performed, bacteria in the small sample size of the waters
would have been in contact and it is known that environ-
mental bacteria rapidly develop resistance to these antibiotics
[20], mainly because they can be reservoirs for the plasmid-
mediated QnrS-like quinolone resistance determinants [21].
Globally a high level of tetracycline-resistance has been
encountered in bacteria found in surface waters. Doxycy-
cline, our test antibiotic, shows in vitro complete cross-
resistance with oxytetracycline, as it has the same mode of
action. In our study, bacterial strains appeared to be relatively
susceptible to doxycycline (between 0 and 30%), despite
higher resistance prevalence being reported in other studies
from aquaculture farms [21]. Higher prevalence of tetracy-
cline resistant genes may be expected in aquaculture farm
waters, where tetracycline is used more intensively [22]. That
aside, the highest prevalence of resistance in isolates from
ReefHQwas expected considering the usage of this antibiotic
while bacteria from Orpheus Island coastal water, which
was expected to have the least antibiotic resistance, were
completely susceptible to doxycycline. High resistance rates
to penicillin andmacrolide antibiotics have been encountered
in a number of other studies. This is often due to intrinsic
resistance of most Gram-negative bacteria [23]. Our study
showed a lower prevalence of resistance to erythromycin (see
Table 2) compared to a similar study from South Carolina
(United States), which found that in rescued sea turtles the
most frequent resistances of Gram-negative isolates were to
erythromycin (95.2%) andpenicillin (95.2%) [17]. Aswehad a
predominantlyGram-negative bacterial population,we chose
to test antibiotic susceptibility to beta-lactam drugs with a
broader spectrum of activity such as ampicillin, ceftiofur, and
amoxiclav. High prevalence of resistance to ampicillin and
amoxiclav was found in studies on antibiotic resistance in
bacteria from aquaculture sources in Australia (54.8% of
isolates resistant to ampicillin) [18], from wild loggerhead
turtles in theMediterranean Sea (77.8% of isolates resistant to
amoxicillin) [15], and from nesting green turtle in the Oman
Sea (∼65% of isolates resistant to ampicillin) [1]. Our results
are similar to the Australian study and lower than the other
studies. The number of beta-lactam drug resistant bacteria
was higher from the coastal waters. Low resistance rates to
ceftiofur have been reported from aquaculture farms in
Australia [18]. This is in contrast with the high resistance
detected in bacterial strains from the two North Queensland
coastal islands isolated in this study. Ceftiofur is a third-
generation cephalosporin beta-lactam drug that has a pre-
ferred spectrum of activity against Gram-negative bacteria.
Therefore, bacteria developing extrinsic resistance to beta-
lactam drugs could be expected to show similar patterns of
resistance to this antibiotic and to the other beta-lactam
drugs. Akinbowale et al. [18] found low levels of resistance to
chloramphenicol (6.7%), attributing this result to the fact that
in Australia it has been removed from use in livestock since
1982, whereas Foti et al. [15] found nearly 40% resistance to
this drug in the Mediterranean Sea. All of these authors
express concern at the spread of multidrug resistant bacteria
in the environment, in aquaculture facilities, and in marine
animal rehabilitation centres. Results in this experiment
support this general concern regarding the fluoroquinolone,
tetracycline, and beta-lactam classes of antibiotics. However,
it was gratifying to note that, despite the use of chlorampheni-
col and potentiated sulphonamides at ReefHQ, the preva-
lence of resistance to them was low. The isolates from the
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rehabilitation centres showed a low level of resistance (10%),
which may be attributed to occasional use of chlorampheni-
col eye ointment to treat eye disease. Bacterial isolates from
both coastal waters showed no resistance to chloramphenicol.
Although, as expected, bacterial resistance to potentiated
sulphonamides was highest in isolates from ReefHQ, the
percentage of resistancewas surprisingly low considering that
this antibiotic is often used for empirical therapy, particularly
of respiratory tract infections. In addition, some of the highly
resistant organisms isolated in this study were primary and
opportunistic pathogens causing various diseases in marine
organisms (V. harveyi) and gastrointestinal illness in humans
(V. parahaemolyticus) [24, 25]. Moreover, a recent study
discouraging sea turtle meat consumption in Mexico found
several human pathogens, including V. parahaemolyticus,
from wild sea turtles to be highly drug resistant [26]. Ninety-
four percent of the V. parahaemolyticus isolates proved to be
resistant to at least one commonly prescribed antibiotic and
mainly to ampicillin, confirming the presence in coastal
environments of multidrug resistant pathogens transmissible
from turtles to humans. The potential for zoonotic disease
transmission in captive sea turtle environments is discussed
by Arena et al. (2014) [27] in a study on a green turtle farm
in the Cayman Islands, where tourists closely interact with
captive animals. Their findings included the isolation of sev-
eral potential human pathogens such asV. alginolyticus, Pseu-
domonas aeruginosa, and Escherichia coli.The possible role of
sea turtles as carriers of human pathogens is also discussed in
a recent studywhich found two strains ofV. parahaemolyticus
on stranded sea turtles along the coast of Italy [28]. Little liter-
ature exists on bacteria isolated from sea turtle eyes [7, 8, 29].
Gram-negatives weremore commonly isolated, reflecting our
results (Table 2). Bacteria in the eyes of sea turtles were
isolated from lesions caused by keratoconjunctivitis, ulcera-
tive blepharitis, ulcerative keratitis, heterophilic scleritis, and
salt gland adenitis. Several potential pathogens were present,
including aeromonads and pseudomonads. These potential
pathogens were found to be multidrug resistant in other
locations [1, 15, 17, 18, 30]. In this experiment, eyes were
considered of particular importance as their contact with the
environment may make them good indicators of water qual-
ity. Our findings add to the existing concern about antibiotic
resistant bacteria in wild and captive sea turtle environments
and emphasise the need for antibiotic alternatives to optimise
therapies in marine reptile rehabilitation centres, which in
turn will reduce the quantity of active antibiotics found in
effluents and of antibiotic resistant bacteria on the epithelia of
turtles that are returned to the ocean.
Phages have been successfully implemented as antibiotic
alternatives in humans [31], marine fish, invertebrates [32],
poultry, and cattle [33]. Our results also show the efficacy of
phage-enriched filtrates in clearingmultidrug resistant bacte-
rial strains.We foundmost of the tested bacteriawere lysed by
phages originating from aquaculture effluents (Table 3). This
was predictable, as the aquaculture effluents were bacterially
richer than the turtle tank water and the greater the bacterial
density in an environment, the greater the phage diversity
[34]. Three of the phage filtrates appeared to be highly spe-
cific, only lysing strain 4, aPseudomonas species, and strain 11,
a Vibrio species. There is a possibility that some of the
phages are broad-spectrum, lysing closely related bacteria;
for example, #6 shows lysis of closely related Vibrio species
only and #4 targets only Pseudomonas species. As the phage
filtrates were not purified, more species of phages may have
been present, including temperate phages that did not lyse the
bacteria or virulent phages with longer latency periods and
therefore did not have the time to produce plaques during
the 24 h incubation period. This may explain why some
phage filtrates cleared bacteria other than the ones they were
enriched with.The apparent broad host range of some phage-
enriched filtrates—for example, phage filtrate #9 lysed both a
Vibrio and Pseudomonas species (Table 3)—may be explained
in the same way. Further isolation and purification of the
filtrates are needed in order to understand the phages’ host
range and select lytic life-cycle phages only. This is possible
as previous studies have successfully isolated and purified
virulent phages that have lysed multidrug resistant strains of
V. harveyi andV. parahaemolyticus originating from aquacul-
ture facilities in Australia and have been able to successfully
treat laboratory mice experimentally infected with V. para-
haemolyticus [31, 35]. Phage therapy has also been proven
highly successful when applied directly onto an infected body
part (e.g., skin, ear, and oral cavity), which may particularly
suit the topical treatment of eye infections in sea turtles
[36]. Furthermore, in the case of enteric infections, thanks
to their high host specificity, phages could be selected to
clear only the targeted bacteria without affecting the turtles’
beneficial microflora [37]. Moreover, phages would be safe to
discharge in turtle rehabilitation centre water effluents, as
once the density of their host bacteria is reduced, they toowill
decrease in number [38]. In the existing literature, phages
have been recommended as antibiotic alternatives for a
variety of animals [31–33].
Asmentioned above, in this study phage filtrates were not
purified and plaque formation was considered to be the result
of lysis by phages as the plaques showed amplification and
not dilution (which would have happened in the presence of
other antimicrobial agents such as bacteriocins [39, 40])
when repeatedly cultured. Nevertheless, in order to add
confidence to our findings, additional analyses will have to
be performed and phage filtrates will have to be purified and
characterized. Given our results, we suggest further investi-
gations with the aim of using phage therapy on sea turtles in
North Queensland rehabilitation centres, not only to control
bacterial diseases but also to reduce the load of antibiotic
resistant bacteria.
5. Conclusion
The prevalence of antibiotic resistance in the bacterial strains
investigated in theNorthQueensland sea turtle rehabilitation
centres and coastal island waters appears to be at alarmingly
high levels for most antibiotics tested. Further investigations
are needed in order to understand how bacteria in rehabilita-
tion centres have developed resistance to antibiotics not used
in those centres. Multidrug resistant bacteria may already
be present in the coastal water taken up by the sea turtle
hospitals, suggesting environmental pollution by antibiotics.
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As the enriched phage filtrates produced plaques in all the
bacterial strains isolated, this study provides promising
results on the efficacy of virulent phages in infecting bacteria
present in sea turtle environments. The practice of assessing
bacterial susceptibility to antibiotics prior to administration
in order to provide themost effective treatment is crucial, and
we emphasise the need for clinical trials and ongoing research
into bacteriophage therapy as antibiotic alternatives for sea
turtles.
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